AtaiBeckley Inc

AtaiBeckley Inc(ATAI)价格预测

$7.290

-0.060 (-0.82%)收盘时

价格预测

1-Day Price Prediction
+0.67%
1-Week Prediction
-1.94%
1-Month Prediction
2026 Prediction
2030 Prediction

在 App 中打开以解锁更长周期的预测。

Loading chart…

ATAI 相似图表分析预测

Alphio's ATAI stock price prediction model matches the current AtaiBeckley Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.34 (+0.67%). The 1-week path is $7.15 (-1.94%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 AtaiBeckley Inc 股票吗?

ATAI Life Sciences NV is not a good buy right now, as the current price of $7.29 is above the downgraded analyst price targets of $7.50 and $8. The stock has experienced a significant decline in analyst ratings due to the pending acquisition by Eli Lilly, which offers a cash payment of $6.75 per share plus contingent payments. Furthermore, the RSI is at 40.989, indicating a lack of momentum for a potential upward move, and the recent 5-day change is down by 1.22%.

ATAI 股价于 Friday 收于 $7.29,此前下跌 -0.82%

AtaiBeckley Inc (ATAI) last closed at $7.29, losing -0.82%. These facts feed the 1-day and 1-week ATAI price prediction above.

预测驱动因素

AtaiBeckley Inc(ATAI)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

相似图表形态

近期走势与 ATAI 最接近的股票,按相似度排序。

ATAI 季节性分析

Historically the probability of a positive August return for ATAI is 65.62%. February offers the highest probability of a positive month at 79.31%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始